146 related articles for article (PubMed ID: 21074267)
1. It takes two-to-leukemia: about addictions and requirements.
Marschalek R
Leuk Res; 2011 Mar; 35(3):424-5. PubMed ID: 21074267
[No Abstract] [Full Text] [Related]
2. t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL.
Kumar AR; Yao Q; Li Q; Sam TA; Kersey JH
Leuk Res; 2011 Mar; 35(3):305-9. PubMed ID: 20869771
[TBL] [Abstract][Full Text] [Related]
3. Significance of AF4-MLL reciprocal fusion in t(4;11) leukemias?
Sanders DS; Muntean AG; Hess JL
Leuk Res; 2011 Mar; 35(3):299-300. PubMed ID: 20952059
[No Abstract] [Full Text] [Related]
4. Authors' comments: t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL.
Kumar AR; Yao Q; Li Q; Sam TA; Kersey JH
Leuk Res; 2011 May; 35(5):697. PubMed ID: 21277021
[No Abstract] [Full Text] [Related]
5. The biological and clinical significance of MLL abnormalities in haematological malignancies.
Mitterbauer-Hohendanner G; Mannhalter C
Eur J Clin Invest; 2004 Aug; 34 Suppl 2():12-24. PubMed ID: 15291802
[TBL] [Abstract][Full Text] [Related]
6. Mixed-phenotype acute leukemia with t(4;11)(q21;q23)
Liu H
Blood; 2019 Mar; 133(11):1265. PubMed ID: 30872272
[No Abstract] [Full Text] [Related]
7. The heterodimerization domains of MLL-FYRN and FYRC--are potential target structures in t(4;11) leukemia.
Pless B; Oehm C; Knauer S; Stauber RH; Dingermann T; Marschalek R
Leukemia; 2011 Apr; 25(4):663-70. PubMed ID: 21233834
[TBL] [Abstract][Full Text] [Related]
8. The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features.
Ragusa D; Makarov EM; Britten O; Moralli D; Green CM; Tosi S
Cancer Rep (Hoboken); 2019 Oct; 2(5):e1207. PubMed ID: 32721124
[TBL] [Abstract][Full Text] [Related]
9. A Novel t(4;11)(q21;q23) MLL-AF4 fusion transcript in infant leukemia.
Abdelhaleem M; Yi Q; Beimnet K; Grant R
Am J Hematol; 2007 Mar; 82(3):247. PubMed ID: 16924642
[No Abstract] [Full Text] [Related]
10. Molecular characterization of identical, novel MLL-EPS15 translocation and individual genomic copy number alterations in monozygotic infant twins with acute lymphoblastic leukemia.
Kotecha RS; Ford J; Beesley AH; Anderson D; Cole CH; Kees UR
Haematologica; 2012 Sep; 97(9):1447-50. PubMed ID: 22581003
[No Abstract] [Full Text] [Related]
11. PDS5A, a novel translocation partner of MLL in acute myeloid leukemia.
Put N; Van Roosbroeck K; Vande Broek I; Michaux L; Vandenberghe P
Leuk Res; 2012 Apr; 36(4):e87-9. PubMed ID: 22230297
[No Abstract] [Full Text] [Related]
12. Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia.
Sait SN; Claydon MA; Conroy JM; Nowak NJ; Barcos M; Baer MR
Cancer Genet Cytogenet; 2007 Sep; 177(2):143-6. PubMed ID: 17854671
[TBL] [Abstract][Full Text] [Related]
13. Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis.
Haddox CL; Mangaonkar AA; Chen D; Shi M; He R; Oliveira JL; Litzow MR; Al-Kali A; Hogan WJ; Elliott MA
Blood Cancer J; 2017 Sep; 7(9):e607. PubMed ID: 29016570
[No Abstract] [Full Text] [Related]
14. Novel variant form of t(11;22)(q23;q13)/MLL-EP300 fusion transcript in the evolution of an acute myeloid leukemia with myelodysplasia-related changes.
Duhoux FP; De Wilde S; Ameye G; Bahloula K; Medves S; Légé G; Libouton JM; Demoulin JB; A Poirel H
Leuk Res; 2011 Mar; 35(3):e18-20. PubMed ID: 20980053
[No Abstract] [Full Text] [Related]
15. Therapy-related B lymphoblastic leukemia with t(4;11)(q21;q23)/AF4-MLL in a patient with mantle cell lymphoma after recent aggressive chemotherapy: a unique case report.
Holdener SL; Harrington L; Nguyen J; Horna P; Sagatys E; Shah B; Zhang L
Int J Clin Exp Pathol; 2014; 7(4):1800-4. PubMed ID: 24817983
[TBL] [Abstract][Full Text] [Related]
16. Identification of a MLL-MLLT4 fusion gene resulting from a t(6;11)(q27;q23) presenting as a del(11q) in a child with T-cell acute lymphoblastic leukemia.
De Braekeleer E; Meyer C; Le Bris MJ; Douet-Guilbert N; Basinko A; Morel F; Berthou C; Marschalek R; Férec C; De Braekeleer M
Leuk Lymphoma; 2010 Aug; 51(8):1570-3. PubMed ID: 20545580
[No Abstract] [Full Text] [Related]
17. Molecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents.
Bennett CA; Winters AC; Barretto NN; Hemenway CS
Leuk Res; 2009 Jul; 33(7):937-47. PubMed ID: 19232721
[TBL] [Abstract][Full Text] [Related]
18. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis.
Daser A; Rabbitts TH
Genes Dev; 2004 May; 18(9):965-74. PubMed ID: 15132992
[No Abstract] [Full Text] [Related]
19. Identification of a novel KMT2A-SEPT14 fusion in acute myeloid leukemia.
Nguyen D; Haley L; Pallavajjala A; Gojo I; Ning Y
Leuk Lymphoma; 2018 Jan; 59(1):265-267. PubMed ID: 28573893
[No Abstract] [Full Text] [Related]
20. 11q23 rearrangement and duplication of MLLT1-MLL gene fusion in therapy-related acute myeloid leukemia.
Chin LK; Cheah CY; Michael PM; MacKinnon RN; Campbell LJ
Leuk Lymphoma; 2012 Oct; 53(10):2066-8. PubMed ID: 22335556
[No Abstract] [Full Text] [Related]
[Next] [New Search]
